The Impact of Atrial Fibrillation on the Cost of Stroke: The Berlin Acute Stroke Study
Open accessAbstract
Objectives Atrial fibrillation (AF) is an important risk factor for stroke. The primary purpose of this study was to determine the resource use for patients admitted to hospital with acute stroke and to calculate stroke-related direct costs, stratifying the results according to the presence of AF as a risk factor.Methods Data from 558 consecutive patients hospitalized with confirmed acute stroke between August 2000 and July 2001 were analyzed as part of the Berlin Acute Stroke Study. Sociodemographic variables were assessed by direct interview, while hospital data were derived from patient medical records. Patients or their carers completed a follow-up questionnaire about resource utilization and absenteeism from work during the 12-month period after hospital admission.Results Out of the 367 patients with follow-up data and ECG findings, 71 (19%) had AF. Patients with AF were generally older, more likely to be female, and had more severe strokes compared with those without AF. Mean direct costs per patient were significantly higher in those with AF-related strokes (EURO 11,799 vs EURO 8817 for non-AF-related strokes; P < 0.001). After adjustment for confounding factors, direct costs were comparable in the two groups, except for acute hospitalization costs, which remained significantly higher in the group with AF (P < 0.05).Conclusion Medical care for stroke patients with AF is associated with higher costs compared with those without AF; this is explained mainly by confounding factors and driven essentially by a significant difference in acute hospitalization costs.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388 · see citing works
Experience from a multicentre stroke register: a preliminary report.
Hatano, S. (1976) · PubMed · Cited by 1,522 · see citing works
A Population-Based Assessment of the Impact and Burden of Caregiving for Long-term Stroke Survivors
Anderson, C. S., Linto, J., & Stewart‐Wynne, E. G. (1995) · Stroke · doi:10.1161/01.str.26.5.843 · Cited by 556 · see citing works
Acute Stroke With Atrial Fibrillation
Jørgensen, H. S., Nakayama, H., Reith, J., Raaschou, H. O., & Olsen, T. S. (1996) · Stroke · doi:10.1161/01.str.27.10.1765 · Cited by 526 · see citing works
Steger, C. M., Pratter, A., Martinek-Bregel, M., Avanzini, M. H., Valentin, A., Slaný, J., & Stöllberger, C. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.030 · Cited by 297 · see citing works
Out-of-hospital delays in patients with acute stroke.
Rossnagel, K., Jungehülsing, G., Nolte, C., Müller-Nordhorn, J., Roll, S., Wegscheider, K., Villringer, A., & Willich, S. (2004) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.06.019 · Cited by 175 · see citing works
Self-citationCost of stroke in Sweden: An incidence estimate
Ghatnekar, O., Persson, U., Glader, E., & Terént, A. (2004) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462304001217 · Cited by 136 · see citing works
Claesson, L., Gosman‐Hedström, G., Johannesson, M., Fagerberg, B., & Blomstrand, C. (2000) · Stroke · doi:10.1161/01.str.31.11.2569 · Cited by 122 · see citing works
Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated?
Miller, P. S. J., Andersson, F., & Kalra, L. (2005) · Stroke · doi:10.1161/01.str.0000153002.56324.8c · Cited by 110 · see citing works
Self-citationManagement Patterns and Health Care Use after Intracerebral Hemorrhage
Weimar, C., Weber, C., Wagner, M., Busse, O., Haberl, R. L., Lauterbach, K. W., & Diener, H. (2003) · Cerebrovascular Diseases · doi:10.1159/000067119 · Cited by 96 · see citing works
Untersuchung zur Reliabilität von Schlaganfallskalen
Berger, K., Weltermann, B., Kolominsky‐Rabas, P. L., et al. (1999) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-993985 · Cited by 83 · see citing works
Anticoagulants for atrial fibrillation: Why is the treatment rate so low?
Buckingham, T. A., & Hatala, R. (2002) · Clinical Cardiology · doi:10.1002/clc.4960251003 · Cited by 72 · see citing works
Gender differences in knowledge of stroke in patients with atrial fibrillation
Nolte, C. H., Rossnagel, K., Jungehuelsing, G. J., Müller‐Nordhorn, J., Roll, S., Reich, A., Willich, S. N., & Villringer, A. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.11.003 · Cited by 27 · see citing works
Self-citationNeurologische Ereignisse bei Patienten mit Vorhofflimmern: Outcome und Präventionspraxis
CARLSSON, J., Miketíc, S., Flicker, E., et al. (2000) · Zeitschrift für Kardiologie · doi:10.1007/s003920070136 · Cited by 9 · see citing works
Barriers to the Use of Warfarin: Potential Solutions
McAnulty, J. H. (2004) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/b:jice.0000011341.67214.2e · Cited by 6 · see citing works
Risk factors in ischemic stroke
Jood, K. (2005) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 4 · see citing works
Risikofaktoren des ischämischen Schlaganfalls
Weih, M., Müller‐Nordhorn, J., Amberger, N., Masuhr, F., Lürtzing, F., Dreier, J. P., & Hetzel, A. (2004) · Der Nervenarzt · doi:10.1007/s00115-003-1639-6 · Cited by 3 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506 · see citing works
A review of the cost of atrial fibrillation
Wodchis, W. P., Bhatia, R. S., Leblanc, K., Meshkat, N., & Morra, D. (2012) · Value in Health · doi:10.1016/j.jval.2011.09.009 · Cited by 109 · see citing works
A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke
Levin, L.-A., Husberg, M., Sobocinski, P. D., Kull, V. F., Friberg, L., Rosenqvist, M., & Davidson, T. (2015) · Europace · doi:10.1093/europace/euu213 · Cited by 56 · see citing works
What are the costs of atrial fibrillation?
Blomstrom Lundqvist, C., Lip, G. Y. H., & Kirchhof, P. (2011) · Europace · doi:10.1093/europace/eur087 · Cited by 42 · see citing works
- Authors
- Brüggenjürgen, B., Rossnagel, K., Roll, S., Andersson, F. L., Selim, D., Müller-Nordhorn, J., Nolte, C. H., Jungehülsing, G. J., Villringer, A., & Willich, S. N.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- AstraZeneca (Sweden) (SE)
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 10
- Issue
- 2
- Pages
- 137-143
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2125757462
- Cited by
- 136
- References
- 19
- Citations by year
- 2025: 4 · 2024: 13 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 11 · 2016: 9 · 2015: 10 · 2014: 13 · 2013: 14 · 2012: 13
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Value in Health (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- atrial fibrillation, stroke, direct costs, healthcare resource utilization, stroke risk factors, absenteeism
- MeSH terms
- Acute Disease, Aged, Aged, 80 and over, Atrial Fibrillation, Berlin, Cost-Benefit Analysis, Demography, Female, Health Resources, Hospitals, Urban, Humans, Male, Middle Aged, Surveys and Questionnaires, Risk Factors, Social Class, Cost of Illness, Hospital Costs, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
